Tissue Regenix Group PLC
LSE:TRX

Watchlist Manager
Tissue Regenix Group PLC Logo
Tissue Regenix Group PLC
LSE:TRX
Watchlist
Price: 0.0725 GBX Market Closed
Market Cap: 5.2m GBX

Wall Street
Price Targets

TRX Price Targets Summary
Tissue Regenix Group PLC

There are no price targets for TRX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Tissue Regenix Group PLC Competitors:
Price Targets
2157
Lepu Biopharma Co Ltd
106% Upside
068270
Celltrion Inc
24% Upside
SBTX
SkinBioTherapeutics PLC
108% Upside
IVVD
Invivyd Inc
166% Upside
2256
Abbisko Cayman Ltd
79% Upside
688278
Xiamen Amoytop Biotech Co Ltd
22% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
33% Upside
301047
Sino Biological Inc
18% Upside

Revenue
Forecast

Revenue Estimate
Tissue Regenix Group PLC

For the last 13 years the compound annual growth rate for Tissue Regenix Group PLC's revenue is 53%. The projected CAGR for the next 2 years is 9%.

53%
Past Growth
9%
Estimated Growth
Estimates Accuracy
3%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Tissue Regenix Group PLC

The compound annual growth rate of Tissue Regenix Group PLC's operating income for the next 2 years is 137%.

N/A
Past Growth
137%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Tissue Regenix Group PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
33%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TRX's stock price target?
Not Available

TRX doesn't have any price targets made by Wall Street professionals.

What is Tissue Regenix Group PLC's Revenue forecast?
Projected CAGR
9%

For the last 13 years the compound annual growth rate for Tissue Regenix Group PLC's revenue is 53%. The projected CAGR for the next 2 years is 9%.

What is Tissue Regenix Group PLC's Operating Income forecast?
Projected CAGR
137%

The compound annual growth rate of Tissue Regenix Group PLC's operating income for the next 2 years is 137%.

Back to Top